Endo International PLC, formerly Endo Health Solutions Inc. is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals …
TheStreet highlights 3 stocks pushing the Drugs industry lower today. Birinyi Associates president Laszlo Biriny opined that maybe the economy will catch up and the stock market may not have strong gains going forwardThe stock
Get detailed financial information on Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) including real-time stock quotes, historical charts & financial news, all for free! ALXA stock quote - Alexza Pharmaceuticals, Inc. stock price ... Stock
Alexza Pharmaceuticals Inc. ALXA priced its offering of 44 million shares and warrants ... compared with the 50-cent offering price. The stock has fallen roughly 16% since the start of the year. The drug company on Thursday said it …
0.5% of Endo International PLC shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. …
Radius Health Inc (NASDAQ:RDUS), Petroleo Brasileiro SA – Petrobras (ADR) (NYSE:PBR) and Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) have been trending today ... which identifies the best small-cap stock picks of the best hedge …
Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) shares are climbed 1.25% to $4.09 the U.S. Food and Drug Administration approves the company’s to start Phase II trial for its rheumatoid arthritis treatment. Subscribe to daily …
MOUNTAIN VIEW, Calif., June 12, 2012 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced a 10-for-1 reverse split of its common stock. The reverse stock split became effective today at 5:01 p.m. Eastern Time and …
Alexza Pharmaceuticals Inc. (ALXA) announced after the bell Friday that it had entered ... since the open Monday and is now up 0.37 at $0.66 on above average volume. The stock has surged to its highest level since early January.
May 3, 2011 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA), or the Company ... in gross proceeds in a registered direct offering through the sale of common stock and warrants. The Company agreed to sell a total of …